Background/Aim: Fucoxanthinol (FxOH) is a marine carotenoid metabolite with potent anti-cancer activity. However, little is known about the efficacy of FxOH in pancreatic cancer. In the present study, we investigated the inhibitory effect of FxOH on six types of cells cloned from amine (BOP)-induced hamster pancreatic cancer (HaPC) cells. Materials and Methods: FxOH action and its molecular mechanisms were investigated in HaPC cells using flow-cytometry, comprehensive gene array, and western blotting analyses. Results: FxOH (5.0 μM) significantly suppressed the growth of four out of six types of HaPC cells. Moreover, FxOH significantly suppressed cell cycle, chemokine, integrin, actin polymerization, microtubule organization and PI3K/AKT and TGF-β signals, and activated caspase-3 followed by apoptosis and anoikis induction in HaPC-5 cells. Conclusion: FxOH may have a high potential as a cancer chemopreventive agent in a hamster pancreatic carcinogenesis model.Pancreatic cancer is one of the most lethal cancers worldwide because it is treatment resistant and has aggressive potential for metastasis/invasion with resultant poor prognosis. From the GLOBOCAN 2018 estimates, 432,242 pancreatic cancer deaths occur per year (4.5% of total) (1), and the 5-year survival rate remains poor at 10% (2). Accumulating evidence suggests that aberrant network integrity of gene mutation, gene methylation, transcriptome, microRNA, non-coding RNA, proteome, tumor microenvironment, and immune cells are crucial for human pancreatic cancer development. In particular, highly carcinogenic point mutations in driver genes, such as KRAS, CDKN2A, TP53, and SMAD4, are observed in many specimens (3-7). Pancreatic intraepithelial neoplasia (PanIN) is a premalignant lesion in pancreatic carcinogenesis and has the stepwise progress graded as four types from mild to severe. KRAS, CDKN2A, TP53 and SMAD4 are somatically mutated in turn along with the malignant progression of PanIN, followed by the cancer progression (8).N-nitrosobis(2-oxopropyl)amine (BOP)-treated Syrian golden hamsters are a chemical carcinogenesis model that represents human pancreatic cancer because it induces PanIN, and pancreatic ductal adenocarcinoma resembles human pancreatic cancer, which also includes similar genetic mutations such as in K-ras, CDKN2A, and SMAD4 (9). Therefore, the BOP-induced hamster pancreatic cancer 407 This article is freely accessible online.